Skip to main content
Duke University Libraries
Search 
  •   DukeSpace
  • Duke Scholarly Works
  • Search
  •   DukeSpace
  • Duke Scholarly Works
  • Search
    • Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 17

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Pharmacy Benefit Management, Cost-Effectiveness Analysis and Drug Formulary Decisions 

    Grabowski, Henry G; Mullins, CD (Social Science & Medicine, 1997-08)
    Thumbnail

    Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act 

    Grabowski, Henry G; Vernon, John M (1992-10)
    IN 1984, Congress enacted a new law that greatly affected the economics of the pharmaceutical industry in the United States. It has been characterized as the most important legislation affecting competition in the pharmaceutical ...
    Thumbnail

    The Role of Cost-Effectiveness Analysis in Managed Care Decisions 

    Grabowski, Henry G (Pharmacoeconomics, 1998)
    Thumbnail

    R&d Costs, Innovative Output and Firm Size in the Pharmaceutical Industry 

    DiMasi, Joseph A; Grabowski, Henry G; Vernon, John M (International Journal of the Economics of Business, 1995-01-01)
    This study examines the relationships between firm size, R&D costs and output in the pharmaceutical industry. Project-level data from a survey of 12 US-owned pharmaceutical firms on drug development costs, development phase ...
    Thumbnail

    Innovation and International Competitiveness in Pharmaceuticals 

    Grabowski, Henry G (Evolving Technology and Market Structure: Studies in Schumpeterian Economics, 1990)
    Thumbnail

    The Costs and Returns to Pharmaceutical Research and Development 

    Grabowski, Henry G (Revista Internazionale di Scienze sociali (International Social Studies Review), 1992-09)
    Thumbnail

    Longer Patents for Increased Genetic Competition: The Waxman-Hatch Act After One Decade 

    Grabowski, Henry G (PharmacoEconomics, 1996)
    Thumbnail

    A New Look at the Returns and Risks to Pharmaceutical R&D 

    Grabowski, Henry G; Vernon, John M (1990-07)
    This study investigates the returns to R&D for 100 new drugs introduced into the United States during the decade of the 1970s. In contrast to prior studies, it incorporates several significant structural changes that have ...
    Thumbnail

    Product Liability in Pharmaceuticals: Comments on Chapters Eight and Nine 

    Grabowski, Henry G (The Liability Maze: The Impact of Liability Law on Safety and Innovation, 1991)
    With an ever-increasing number of liability lawsuits, are corporations electing to play it safe rather than risk the uncertainties accompanying innovation? In The Liability Maze experts address the issues surrounding safety ...
    Thumbnail

    Economic Evaluation of Drug Treatment for Psychiatric Disorders: The New Clinical Trial Protocol 

    Bannerman, Heather A; Grabowski, Henry G; Mauskopf, Josephine; Weisler, Ricard H; Zarkin, Gary A (Psychopharmacology: the Fourth Generation of Progress, 1995)
    • 1
    • 2
     

     

    Browse

    All of DukeSpaceCommunities & CollectionsAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit DateThis CommunityAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit Date

    My Account

    LoginRegister

    Discover

    Author
    Grabowski, Henry G (17)
    Vernon, John M (4)DiMasi, Joseph A (2)Vernon, John (2)Bannerman, Heather A (1)Hansen, Ronald W (1)Lasagna, L (1)Mauskopf, Josephine (1)Mullins, CD (1)Weisler, Ricard H (1)... View MoreDate Issued1990 (3)1991 (3)1994 (3)1995 (3)1992 (2)1996 (1)1997 (1)1998 (1)TypeJournal article (12)Book section (5)SubjectCosts and Cost Analysis (2)Data Collection (2)Drug Industry (2)United States (2)Business & Economics (1)Commerce (1)Data Interpretation, Statistical (1)Drug Evaluation (1)Drug Evaluation, Preclinical (1)Drugs, Investigational (1)... View MoreAffiliation of Duke Author(s)Duke (15)Economics (15)Trinity College of Arts & Sciences (15)